PARPARADIGM BIOPHARMACEUTICALS LIMITED..Market sensitive

Drawdown of Tranche 4 under the Convertible Note Facility

Date and time
Announcement type
Securities Administration

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case